Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0041 | 0.0345 | 0.1263 |
Onchocerca volvulus | 0.0024 | 0.0043 | 0.0137 | |
Schistosoma mansoni | hypothetical protein | 0.0098 | 0.1406 | 0.1406 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0031 | 0.0163 | 0.5 |
Entamoeba histolytica | beta-galactosidase, putative | 0.0098 | 0.1406 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0024 | 0.0043 | 0.0043 |
Echinococcus granulosus | neutral alpha glucosidase AB | 0.0031 | 0.0163 | 0.0163 |
Echinococcus granulosus | beta mannosidase | 0.0066 | 0.0803 | 0.0803 |
Brugia malayi | manba-prov protein | 0.0156 | 0.2476 | 0.9063 |
Loa Loa (eye worm) | manba-prov protein | 0.0066 | 0.0803 | 0.2939 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0139 | 0.2161 | 0.7911 |
Plasmodium vivax | SET domain protein, putative | 0.0024 | 0.0043 | 0.5 |
Brugia malayi | Pre-SET motif family protein | 0.0024 | 0.0043 | 0.0159 |
Schistosoma mansoni | alpha-glucosidase | 0.012 | 0.1804 | 0.1804 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0345 | 0.1263 |
Trichomonas vaginalis | glycoside hydrolase, putative | 0.0189 | 0.3079 | 0.9713 |
Trichomonas vaginalis | beta-mannosidase, putative | 0.0066 | 0.0803 | 0.2131 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0024 | 0.0043 | 0.0043 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0031 | 0.0163 | 0.0597 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0024 | 0.0043 | 0.0043 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0041 | 0.0345 | 0.1263 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0139 | 0.2161 | 0.7911 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0564 | 1 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0024 | 0.0043 | 0.0043 |
Brugia malayi | Pre-SET motif family protein | 0.017 | 0.2732 | 1 |
Onchocerca volvulus | 0.0194 | 0.3165 | 1 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0189 | 0.3079 | 0.9713 |
Schistosoma mansoni | alpha-glucosidase | 0.012 | 0.1804 | 0.1804 |
Schistosoma mansoni | alpha glucosidase | 0.0031 | 0.0163 | 0.0163 |
Schistosoma mansoni | beta-mannosidase | 0.0066 | 0.0803 | 0.0803 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0024 | 0.0043 | 0.0043 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0139 | 0.2161 | 0.2161 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.017 | 0.2732 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0043 | 0.0159 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0139 | 0.2161 | 0.2161 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0024 | 0.0043 | 0.0043 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0139 | 0.2161 | 0.2161 |
Loa Loa (eye worm) | beta-glucuronidase | 0.0091 | 0.1267 | 0.4636 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0031 | 0.0163 | 0.0597 |
Loa Loa (eye worm) | glycosyl hydrolase family 2 | 0.0098 | 0.1406 | 0.5147 |
Schistosoma mansoni | hypothetical protein | 0.0028 | 0.0107 | 0.0107 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0028 | 0.0107 | 0.0393 |
Trypanosoma brucei | glucosidase, putative | 0.0031 | 0.0163 | 0.5 |
Trichomonas vaginalis | beta-galactosidase, putative | 0.0189 | 0.3079 | 0.9713 |
Onchocerca volvulus | 0.008 | 0.1078 | 0.3407 | |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0024 | 0.0043 | 0.0043 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0031 | 0.0163 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0031 | 0.0163 | 0.5 |
Trichomonas vaginalis | set domain proteins, putative | 0.0194 | 0.3165 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0107 | 0.0393 |
Brugia malayi | Beta-glucuronidase precursor | 0.0091 | 0.1267 | 0.4636 |
Echinococcus multilocularis | beta mannosidase | 0.0066 | 0.0803 | 0.0803 |
Brugia malayi | Glycosyl hydrolases family 2, sugar binding domain containing protein | 0.0098 | 0.1406 | 0.5147 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0031 | 0.0163 | 0.5 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0023 | 0.0027 | 0.0027 |
Echinococcus multilocularis | neutral alpha glucosidase AB | 0.0031 | 0.0163 | 0.0163 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0564 | 1 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0041 | 0.0345 | 0.1263 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 30 uM | Antagonist activity at N-terminal His6-tagged L3MBTL1 (unknown origin) expressed in Escherichia coli BL21 Codon Plus RIL cells assessed as inhibition of L3MBTL1/biotinylated H4K20Me1 peptide interaction after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
IC50 (binding) | > 30 uM | Antagonist activity at His-tagged L3MBTL3 (unknown origin) assessed as inhibition of L3MBTL3/biotinylated H4K20Me2 peptide interaction after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
IC50 (binding) | > 30 uM | Antagonist activity at L3MBTL4 (unknown origin) assessed as inhibition of L3MBTL4/biotinylated H2AK36Me1 peptide interaction after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
IC50 (binding) | > 30 uM | Antagonist activity at MBTD1 (unknown origin) assessed as inhibition of MBTD1/biotinylated H4K20Me1 peptide interaction after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
IC50 (binding) | > 30 uM | Antagonist activity at SFMBT1 (unknown origin) assessed as inhibition of SFMBT1/biotinylated H3K9Me1 peptide interaction after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
IC50 (binding) | > 30 uM | Antagonist activity at Flag-tagged CBX7 (unknown origin) assessed as inhibition of CBX7/biotinylated H3K9Me3 peptide interaction after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
Inhibition (binding) | Antagonist activity at Flag-tagged CBX7 (unknown origin) assessed as inhibition of CBX7/biotinylated H3K9Me3 peptide interaction at 30 uM after 30 mins by AlphaScreen assay | ChEMBL. | No reference | |
Inhibition (binding) | Antagonist activity at L3MBTL4 (unknown origin) assessed as inhibition of L3MBTL4/biotinylated H2AK36Me1 peptide interaction at 30 uM after 30 mins by AlphaScreen assay | ChEMBL. | No reference | |
Inhibition (binding) | Antagonist activity at SFMBT1 (unknown origin) assessed as inhibition of SFMBT1/biotinylated H3K9Me1 peptide interaction at 30 uM after 30 mins by AlphaScreen assay | ChEMBL. | No reference | |
Inhibition (binding) | = 1 % | Antagonist activity at MBTD1 (unknown origin) assessed as inhibition of MBTD1/biotinylated H4K20Me1 peptide interaction at 30 uM after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
Inhibition (binding) | = 5 % | Antagonist activity at N-terminal His6-tagged L3MBTL1 (unknown origin) expressed in Escherichia coli BL21 Codon Plus RIL cells assessed as inhibition of L3MBTL1/biotinylated H4K20Me1 peptide interaction at 30 uM after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
Inhibition (binding) | = 18 % | Antagonist activity at His-tagged L3MBTL3 (unknown origin) assessed as inhibition of L3MBTL3/biotinylated H4K20Me2 peptide interaction at 30 uM after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
Kd (binding) | Binding affinity to L3MBTL1 (unknown origin) by isothermal titration calorimetry | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.